Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic NK Cells in Recurrent Ovarian Cancer
NCT00652899Phase 2Terminated
- Sponsor
- Masonic Cancer Center
- Start
- Mar 2008
- Primary completion
- Aug 2009
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Lymphokine-Activated Killer Cells
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic natural killer cells in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Masonic Cancer Center. Started Mar 2008; status: terminated.
02
Drugs
allogeneic natural killer cells
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00652899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652899.